Suicide Prevention in Schizophrenia: Do Long-Acting Injectable Antipsychotics (LAIs) have a Role?-Reference-Cited by-同舟云学术

Suicide Prevention in Schizophrenia: Do Long-Acting Injectable Antipsychotics (LAIs) have a Role?

Published:2017-07-05 Issue:4 Volume:16 Page:
ISSN:1871-5273
Container-title:CNS & Neurological Disorders - Drug Targets
language:en
Short-container-title:CNSNDDT

Author:

Pompili Maurizio¹,Orsolini Laura²,Lamis Dorian A.³,Goldsmith David R.³,Nardella Adele⁴,Falcone Giulia⁴,Corigliano Valentina⁵,Luciano Mario⁶,Fiorillo Andrea⁶

Affiliation:

1. Department of Psychiatry, Sant’Andrea Hospital, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy

2. University of Hertfordshire, Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, United Kingdom

3. Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, United States

4. Psychiatry Residency Training Program, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy

5. Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy

6. Department of Psychiatry, University of Naples SUN, Naples, Italy

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,General Neuroscience

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers;Journal of Psychopharmacology;2024-09-12

2. How can we better address the pharmacokinetics of antipsychotics in children and adolescents?;Expert Opinion on Drug Metabolism & Toxicology;2024-07-12

3. A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder;Asian Journal of Psychiatry;2024-04

4. Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes;Biomedicines;2024-01-12

5. Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety;Neuropsychiatric Disease and Treatment;2023-10